References
1. Ubago JL, Figueroa A, Colman T, Ochoteco A, Duran CG.Hemodynamic Factors That Affect Calculated Orifice Areas in the Mitral Hancock Xenograft Valve. Circulation. 1980 Feb;61(2):388-94.
2. Yoon S-H, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J 2019;40:441–451.
3. Russell HM, Guerrero ME, Salinger MH, et al. Open atrial transcatheter mitral valve replacement in patients with mitral annular calcification. J Am Coll Cardiol 2018;72:1437–1448.
4. Babaliaros VC, Greenbaum AB, Khan JM, et al. Intentional percutaneous laceration of the anterior mitral leaflet to prevent out- flow obstruction during transcatheter mitral valve replacement: first-in-human experience. JACC Cardiovasc Interv 2017;10:798–809.
5. Whisenant B, Kapadia SR, Eleid MF, et al. One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve. JAMA Cardiol. 2020. doi:10.1001/jamacardio.2020.2974.
6. Kiefer P, Noack T, Seeburger J, et al. Transapical Mitral Valve Implantation for Native Mitral Valve Stenosis Using a Balloon-Expandable Prosthesis. Ann Thorac Surg. 2017 Dec;104(6):2030-2036.
7. Flameng W, Rega F, Vercalsteren M, Herijgers P, Meuris B.Antimineralization Treatment and Patient-Prosthesis Mismatch Are Major Determinants of the Onset and Incidence of Structural Valve Degeneration in Bioprosthetic Heart Valves. J Thorac Cardiovasc Surg. 2014 Apr;147(4):1219-24.